Source / episode info

• **Episode:**262
• **Title:**Divine Intervention Episode 262 – The Clutch TB Podcast.
• **Published:**2020-09-18
• Source:Episode page

One-liner

This episode provides a comprehensive review of tuberculosis management, covering the appropriate use of Tuberculin Skin Test (TST) versus Interferon Gamma Release Assay (IGRA), differentiating latent from active TB disease, managing MAC infections, and interpreting CSF findings in TB meningitis.

High-yield summary

• Screening Choice: If a patient has received the BCG vaccine, IGRA is preferred over TST for screening purposes; also use IGRA in immunocompromised patients (e.g., transplant recipients).
• TB Diagnosis Distinction: Neither TST nor IGRA can differentiate between active and latent TB infection; this distinction requires clinical correlation with symptoms, CXR findings, and microbiological testing.
• Latent TB Criteria: Requires three conditions: 1) Positive TST/IGRA, 2) Negative chest X-ray (CXR), and 3) Absence of systemic TB manifestations (e.g., cough, fever). Treatment is typically Isoniazid for 9 months + Vitamin B6.
• Active TB Diagnosis: Requires clinical symptoms (cough, hemoptysis, night sweats, etc.) AND CXR findings AND positive sputum culture/PCR. The gold standard remains sputum culture.
• MAC Infection Clues: In non-HIV patients, suspect MAC infection if the patient is an elderly, thin white female with a connective tissue disorder and signs of chronic lung disease (e.g., pectothorax, scoliosis). Treatment involves Macrolides (Erythromycin/Clarithromycin).
• TB Meningitis CSF: Characteristically shows high opening pressure, elevated protein, predominantly lymphocytic pleocytosis, and low glucose. PCR is the best diagnostic test.

Learning objectives

• Differentiate the appropriate use of TST versus IGRA based on patient history (e.g., BCG status, immunocompromised state).
• Establish the diagnostic criteria for Latent TB Infection (LTBI) vs. Active Tuberculosis Disease.
• Identify key clinical and radiological findings suggestive of MAC infection in non-HIV patients.
• Interpret CSF parameters to support a diagnosis of TB meningitis.
• Select appropriate prophylactic monitoring tests before starting first-line anti-TB regimens (e.g., Pyrazinamide, Ethambutol).